FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 251 filers reported holding FATE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.41 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,074 | -54.7% | 977,862 | +1.6% | 0.00% | -100.0% |
| Q2 2023 | $4,580 | -46.4% | 962,158 | -35.9% | 0.00% | 0.0% |
| Q1 2023 | $8,551 | -68.1% | 1,500,032 | -43.6% | 0.00% | -75.0% |
| Q4 2022 | $26,829 | -100.0% | 2,659,058 | -15.4% | 0.00% | -66.7% |
| Q3 2022 | $70,405,000 | -43.0% | 3,141,653 | -37.0% | 0.01% | -25.0% |
| Q2 2022 | $123,491,000 | -35.1% | 4,983,503 | +1.5% | 0.02% | -15.8% |
| Q1 2022 | $190,414,000 | -17.3% | 4,911,367 | +24.8% | 0.02% | -9.5% |
| Q4 2021 | $230,175,000 | -1.8% | 3,933,938 | -0.6% | 0.02% | -4.5% |
| Q3 2021 | $234,501,000 | -13.1% | 3,956,495 | +27.2% | 0.02% | -12.0% |
| Q2 2021 | $269,902,000 | +4.0% | 3,109,832 | -1.2% | 0.02% | -3.8% |
| Q1 2021 | $259,644,000 | -18.7% | 3,149,106 | -10.3% | 0.03% | -21.2% |
| Q4 2020 | $319,253,000 | +241.7% | 3,510,970 | +50.2% | 0.03% | +200.0% |
| Q3 2020 | $93,424,000 | +115.8% | 2,337,345 | +85.2% | 0.01% | +120.0% |
| Q2 2020 | $43,297,000 | +121.8% | 1,261,945 | +43.6% | 0.01% | +66.7% |
| Q1 2020 | $19,522,000 | +1.5% | 878,963 | -10.5% | 0.00% | +50.0% |
| Q4 2019 | $19,229,000 | +4.1% | 982,581 | -17.4% | 0.00% | -33.3% |
| Q3 2019 | $18,469,000 | -23.4% | 1,189,262 | +0.1% | 0.00% | 0.0% |
| Q2 2019 | $24,113,000 | +9.9% | 1,187,839 | -4.9% | 0.00% | 0.0% |
| Q1 2019 | $21,941,000 | +86.6% | 1,248,782 | +36.2% | 0.00% | +50.0% |
| Q4 2018 | $11,760,000 | -11.2% | 916,624 | +12.7% | 0.00% | 0.0% |
| Q3 2018 | $13,247,000 | +48.0% | 813,195 | +3.1% | 0.00% | +100.0% |
| Q2 2018 | $8,948,000 | -4.8% | 789,096 | -18.0% | 0.00% | 0.0% |
| Q1 2018 | $9,397,000 | +192.7% | 962,773 | +83.2% | 0.00% | 0.0% |
| Q4 2017 | $3,211,000 | – | 525,607 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co. V, L.L.C. | 569,889 | $51,820,000 | 67.63% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,379,064 | $307,258,000 | 39.62% |
| Darwin Global Management, Ltd. | 952,847 | $86,642,000 | 24.18% |
| Redmile Group, LLC | 12,629,737 | $1,148,422,000 | 13.91% |
| DAFNA Capital Management LLC | 334,360 | $30,403,000 | 9.05% |
| Casdin Capital, LLC | 3,050,000 | $277,337,000 | 8.22% |
| Grosvenor Holdings, L.L.C. | 1,459,517 | $132,714,000 | 7.23% |
| Copernicus Capital Management, LLC | 3,240 | $295,000 | 4.60% |
| Eversept Partners, LP | 399,499 | $36,326,444 | 4.26% |
| Ally Bridge Group (NY) LLC | 260,000 | $23,642,000 | 4.05% |